Azenta
- Market cap
- 1.57B
- P/E (TTM)i
- -13.34
- P/Bi
- 1.04
- EPSi
- -1.22
- Div yieldi
- 0.00%
- 52W posi
- 65%
Anonymous reader poll. Unscientific, not investment advice.
About Azenta
Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company offers a suite of reliable cold-chain sample management solutions and multiomics services supporting drug development, clinical research, and advanced cell therapies for pharmaceutical, biotechnology, academic, and healthcare institutions globally. It operates through the following segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment provides end-to-end sample management products and services, including Sample Repository Services (SRS). Its core products include automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled-rate thawing devices. The Multiomics segment delivers genomic and other sample analysis services, including gene sequencing, gene synthesis, and related services. The company was founded in 1978 and is headquartered in Burlington, MA.
- Founded
- 1978
- CEO
- Dr. Martin D. Madaus,PhD
- Employees
- 3,000
- Headquarters
- Burlington, Massachusetts, United States of America
- Fiscal year end
- 09-30
- Website
- azenta.com
Company profile
- Exchange
- US
- Symbol
- AZTA
- Market-cap rank
- #2893
- Listing date
- 1970-01-01
- Market cap
- 1.57B
- Float cap
- 1.40B
- Shares out
- 43.81M
- Float shares
- 38.88M
Sectors & themes
Quote time 2026-10-08 07:20:54 · For reference only, not investment advice and not tailored to your situation.